Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for Sandhoff disease, juvenile form has been reported in the published literature.
No clinical trials have been registered for Sandhoff disease, juvenile form.
5 publications have been identified in PubMed for Sandhoff disease, juvenile form. Research spans Diagnostic / Biomarker (20%), Review / Meta-Analysis (20%), and Basic Science / Preclinical (20%).
Platt N (2025). [PMID: 39791736](https://pubmed.ncbi.nlm.nih.gov/39791736/). *Cells*. [Basic Science / Preclinical]
González-Sánchez M (2025). [PMID: 40710901](https://pubmed.ncbi.nlm.nih.gov/40710901/). *Neurology international*. [Review / Meta-Analysis]
Rodriguez MB (2025). [PMID: 41267078](https://pubmed.ncbi.nlm.nih.gov/41267078/). *Orphanet journal of rare diseases*. [Epidemiology / Natural History]
Su Q (2024). [PMID: 39246358](https://pubmed.ncbi.nlm.nih.gov/39246358/). *Chemical science*. [Gene Therapy / Novel Therapeutics]
Lewis CJ (2024). [PMID: 39802759](https://pubmed.ncbi.nlm.nih.gov/39802759/). *medRxiv : the preprint server for health sciences*. [Diagnostic / Biomarker]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 4:30 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Sandhoff disease, juvenile form
AI-curated news mentioning Sandhoff disease, juvenile form
Updated May 5, 2026
A recent study explores adult-onset Sandhoff disease, revealing a motor neuron disease phenotype through patient-derived models. This research provides new mechanistic insights that could inform future therapeutic strategies.
Researchers have successfully generated and characterized induced pluripotent stem cell lines from patients with Tay-Sachs and Sandhoff disease. This advancement may facilitate further studies into the pathophysiology and potential therapies for these lysosomal storage disorders.